RK
Raj Kumar Meghwanshi
About Raj Kumar Meghwanshi
Data last updated:
Raj Kumar Meghwanshi is a Director at Antariksh Multi Pharma Products Private Limited (since 2023) and Director at Ingenevo Chemex Private Limited (since 2023). The companies operate in Chemicals and Materials and Trading. Earlier, Raj Kumar Meghwanshi was a Director at Spanmed Pharmaceuticals Private Limited (2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Aug 2023 | 2023 | Active | ||
| Director | 17 Aug 2023 | 2020 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Sep 2023 | 2019 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Raj Kumar Meghwanshi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Naresh Singh Devara | 08669879 | Antariksh Multi Pharma Products Private Limited , Ingenevo Chemex Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raj Kumar Meghwanshi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raj Kumar Meghwanshi
Raj Kumar Meghwanshi currently holds 2 directorships: Antariksh Multi Pharma Products Private Limited (Director, since 20 Aug 2023); Ingenevo Chemex Private Limited (Director, since 17 Aug 2023).
Raj Kumar Meghwanshi was first appointed on 17 Aug 2023 as Director at Ingenevo Chemex Private Limited.
Raj Kumar Meghwanshi held 1 earlier board appointment: Spanmed Pharmaceuticals Private Limited (Director, 06 Sep 2023 to 17 Oct 2023).
The current boards of Raj Kumar Meghwanshi's companies include Naresh Singh Devara (Antariksh Multi Pharma Products Private Limited).